A citation-based method for searching scientific literature

Howard Sofen, Stacy Smith, Robert T Matheson, Craig L Leonardi, Cesar Calderon, Carrie Brodmerkel, Katherine Li, Kim Campbell, Stanley J Marciniak, Yasmine Wasfi, Yuhua Wang, Philippe Szapary, James G Krueger. J Allergy Clin Immunol 2014
Times Cited: 190



Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley, Mamitaro Ohtsuki, Mary Flack, Ziqian Geng, Yihua Gu, Joaquin M Valdes, Elizabeth H Z Thompson, Hervé Bachelez. Lancet 2018
Times Cited: 264




List of shared articles



Times cited

Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.
Sang Woong Youn, Dae Young Yu, Tae Yoon Kim, Byung Soo Kim, Seung Chul Lee, Jeung Hoon Lee, Yong-Beom Choe, Joo-Heung Lee, Jee-Ho Choi, Joo Young Roh,[...]. J Dermatolog Treat 2022
1

T-cell subsets in the skin and their role in inflammatory skin disorders.
Inge Kortekaas Krohn, Joeri L Aerts, Karine Breckpot, Cleo Goyvaerts, Edward Knol, Femke Van Wijk, Jan Gutermuth. Allergy 2022
4

Immunobiologicals in dermatology.
Dimitri Luz Felipe da Silva, Elisa Nunes Secamilli, Mariana Valbon Beleli, Juliana Yumi Massuda, Andrea F E C Franca, Renata F Magalhães. An Bras Dermatol 2022
0

What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
Mario Valenti, Alessandra Narcisi, Giulia Pavia, Luigi Gargiulo, Antonio Costanzo. J Crohns Colitis 2022
0

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2022
0

Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis.
Nikolai Loft, Anne-Sofie Halling, Alexander Egeberg, Lone Skov. J Am Acad Dermatol 2021
9



Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach. Cochrane Database Syst Rev 2021
21

Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
Robert Gironés Petit, Amanda Cano, Alba Ortiz, Marta Espina, Josefina Prat, Montserrat Muñoz, Patrícia Severino, Eliana B Souto, Maria L García, Montserrat Pujol,[...]. Int J Mol Sci 2021
6

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab.
Feras M Ghazawi, Farhan Mahmood, Leon Kircik, Yves Poulin, Marc Bourcier, Ronald Vender, Marni C Wiseman, Charles Lynde, Ivan V Litvinov. Front Med (Lausanne) 2021
4


Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Sivem Afach, Liz Doney, Corinna Dressler, Camille Hua, Canelle Mazaud, Céline Phan, Carolyn Hughes, Dru Riddle,[...]. Cochrane Database Syst Rev 2020
78

Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis.
Karen M Page, Mayte Suarez-Farinas, Maria Suprun, Weidong Zhang, Sandra Garcet, Judilyn Fuentes-Duculan, Xuan Li, Matthew Scaramozza, Elizabeth Kieras, Christopher Banfield,[...]. J Invest Dermatol 2020
20

Interleukin 23 and autoimmune diseases: current and possible future therapies.
Ahmad Ismail Khaled Abdo, Gee Jun Tye. Inflamm Res 2020
6

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.
Joshua S Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle. Clin Microbiol Rev 2020
27

The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment.
Lisa Lynn Ten Bergen, Aleksandra Petrovic, Anders Krogh Aarebrot, Silke Appel. Scand J Immunol 2020
15

The Immunobiology of the Interleukin-12 Family: Room for Discovery.
Elia D Tait Wojno, Christopher A Hunter, Jason S Stumhofer. Immunity 2019
160

Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.
J J Crowley, R B Warren, J C Cather. J Eur Acad Dermatol Venereol 2019
37


Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies.
Ting-Ting Zhang, Junli Ma, Kenneth R Durbin, Timothy Montavon, Susan E Lacy, Gary J Jenkins, Stella Doktor, J Cory Kalvass. AAPS J 2019
3

Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.
Kristian Reich, April W Armstrong, Richard G Langley, Susan Flavin, Bruce Randazzo, Shu Li, Ming-Chun Hsu, Patrick Branigan, Andrew Blauvelt. Lancet 2019
125

Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis.
Shanshan Xu, Xiaoyi Zhang, Meijuan Pan, Zongwen Shuai, Shengqian Xu, Faming Pan. Int Immunopharmacol 2019
12

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
Todd Wechter, Abigail Cline, Steven R Feldman. Ther Clin Risk Manag 2018
8